GeoVax Labs, Inc.
USD1.27
-0.01 (-0.78%)
CEO
David Alan Dodd
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.27
Prev. Close
$1.28
Day Low
$1.24
Day High
$1.29
52W Low
$0.96
52W High
$23.10
Market Cap
$0.00B
Volume
0.13M
| -0.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -450.6% | -279.7% | 0.00 | 2.24 | -0.5 |
| 31 Dec 2022 | FY | -11090.9% | -17198.3% | -52.7% | -44.7% | 0.00 | 6.10 | -1.7 |
| 31 Dec 2021 | FY | 100.0% | -4817.2% | -425.7% | -157.4% | 0.00 | 2.14 | -7.4 |
| 31 Dec 2020 | FY | 100.0% | -162.2% | -30.9% | -28.5% | 0.02 | 12.63 | -43.5 |
| 31 Dec 2019 | FY | 100.0% | -201.6% | 150.6% | -505.6% | -0.03 | 0.22 | -192.8 |
| 31 Dec 2018 | FY | -95.1% | -265.8% | 250.5% | -398.8% | -0.29 | 0.38 | -9524531.3 |
| 31 Dec 2017 | FY | -87.6% | -201.8% | 675.9% | -442.7% | 0.00 | 0.55 | -23407238.7 |
| 31 Dec 2016 | FY | -137.8% | -394.7% | -1361.1% | -536.2% | 0.00 | 1.47 | -19252645.6 |
| -0.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -128.8% | -93.9% | 0.00 | 3.57 | -0.4 |
| 30 Jun 2025 | Q2 | 100.0% | -630.0% | -190.3% | -100.4% | 0.00 | 2.03 | -0.6 |
| 31 Mar 2025 | Q1 | 100.0% | -327.3% | -67.8% | -49.5% | 0.00 | 3.62 | -0.6 |
| 31 Dec 2024 | Q4 | 97.5% | -955.9% | -163.7% | -101.3% | 0.00 | 2.55 | -0.8 |
| 30 Sept 2024 | Q3 | 100.0% | -208.5% | -68.4% | -52.3% | 0.00 | 4.17 | -0.7 |
| 30 Jun 2024 | Q2 | 100.0% | -1684.2% | 219.3% | -123.7% | -0.06 | 0.60 | -0.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -10778.7% | -174.2% | 0.00 | 0.87 | -0.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -131.7% | -81.8% | 0.00 | 2.24 | -0.5 |